Han Cui
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 5
- Oncology 9
- Bone health and treatments 3
- Metal complexes synthesis and properties 3
- Co-authors
- Siyuan Zhou (18 shared papers)Qibing Mei (15 shared papers)Daozhou Liu (10 shared papers)Miao Liu (13 shared papers)Bang‐Le Zhang (15 shared papers)Ying Cheng (8 shared papers)Ying Cheng (3 shared papers)Meng‐Lei Huan (7 shared papers)
- Journals
- Molecular Pharmaceutics (4 papers)Nanomedicine Nanotechnology Biology and Medicine (3 papers)PLoS ONE (2 papers)Journal of Pharmaceutical Sciences (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Han Cui
20 papers receiving 820 citations
Peers
Comparison fields: 5 of 92
- Geriatrics and Gerontology 76
- Biomaterials 249
- Pathology and Forensic Medicine 101
- Molecular Medicine 27
- Molecular Biology 371
Countries citing papers authored by Han Cui
This map shows the geographic impact of Han Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Cui more than expected).
Fields of papers citing papers by Han Cui
This network shows the impact of papers produced by Han Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Cui. The network helps show where Han Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Han Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 180 | |
| 2 | 2013 | 130 | |
| 3 | 2016 | 96 | |
| 4 | 2019 | 63 | |
| 5 | 2018 | 55 | |
| 6 | 2017 | 44 | |
| 7 | 2014 | 39 | |
| 8 | 2017 | 38 | |
| 9 | 2016 | 25 | |
| 10 | 2019 | 24 | |
| 11 | 2012 | 23 | |
| 12 | 2018 | 19 | |
| 13 | 2012 | 18 | |
| 14 | 2017 | 17 | |
| 15 | 2012 | 15 | |
| 16 | 2019 | 14 | |
| 17 | 2018 | 11 | |
| 18 | 2014 | 10 | |
| 19 | 2013 | 5 | |
| 20 | 2024 | 3 |
About Han Cui
Han Cui is a scholar working on Molecular Biology, Oncology, Biomaterials, Biomedical Engineering and Pathology and Forensic Medicine, having authored 21 papers that have together received 829 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers), RNA Interference and Gene Delivery (5 papers), Bone health and treatments (3 papers), Metal complexes synthesis and properties (3 papers), MicroRNA in disease regulation (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Geriatrics and Gerontology (76 citations), Biomaterials (249 citations), Pathology and Forensic Medicine (101 citations), Molecular Medicine (27 citations) and Molecular Biology (371 citations). Han Cui has collaborated with scholars based in China and United States. Frequent co-authors include Siyuan Zhou, Qibing Mei, Daozhou Liu, Miao Liu, Bang‐Le Zhang, Ying Cheng, Ying Cheng, Meng‐Lei Huan, Zenghui Teng and Tiehong Yang. Their work appears in journals such as Molecular Pharmaceutics, Nanomedicine Nanotechnology Biology and Medicine, PLoS ONE, Journal of Pharmaceutical Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.